Skip to main content
. 2021 Feb 2;96(5):e671–e683. doi: 10.1212/WNL.0000000000011226

Figure 4. Relationship Between Plasma Biomarkers and Cortical Thickness in Frontotemporal Lobar Degeneration Syndromes (FTLD-S) and Alzheimer Disease Syndromes (AD-S) Groups.

Figure 4

Group comparison of cortical thickness between healthy controls (HC) and FTLD-S (A) and AD-S (B). Correlation between basal plasma levels of tau and cortical thickness in FTLD-S group (C); correlation between basal plasma levels of total tau (t-tau) and cortical thickness in AD-S group (D); correlation between basal plasma levels of NfL and cortical thickness in FTLD-S group (E); correlation between basal plasma levels of NfL and cortical thickness in AD-S group (F). For group comparisons, only clusters that survived false discovery rate correction (p < 0.05) are shown. For correlation analyses (C–F), the threshold for statistically significant correlation was set at p < 0.001.